University of Groningenfounded in 1614  -  top 100 university
Close
About us How to find us prof. dr. M.J. (Maarten) Postma

prof. dr. M.J. (Maarten) Postma

Professor Global Health Economics UMCG & RUG

prof. dr. M.J. (Maarten) Postma
Telephone:
+31 50 361 5084 (secretary)
E-mail:
m.j.postma rug.nl

Research

Research units:

Advanced
Advanced

Reset

to
1 - 50 out of 665Page size: 50
  1. 2020
  2. FRESH AIR Collaborators, Brakema, E. A., van der Kleij, R. M., Vermond, D., van Gemert, F. A., & Kirenga, B. (2020). Let’s stop dumping cookstoves in local communities. It’s time to get implementation right. npj Primary Care Respiratory Medicine, 30(1), [3]. https://doi.org/10.1038/s41533-019-0160-8
  3. Arifin, B., Purba, F. D., Herman, H., Adam, J. M. F., Atthobari, J., Schuiling-Veninga, C. C. M., ... Postma, M. J. (2020). Comparing the EQ-5D-3 L and EQ-5D-5 L : studying measurement and scores in Indonesian type 2 diabetes mellitus patients. HEALTH AND QUALITY OF LIFE OUTCOMES, 18(1), 22. https://doi.org/10.1186/s12955-020-1282-y
  4. van Aalst, R., Gravenstein, S., Mor, V., Mahmud, S. M., Wilschut, J., Postma, M., & Chit, A. (2020). Comparative effectiveness of high dose versus adjuvanted influenza vaccine: A retrospective cohort study. Vaccine, 38(2), 372-379. https://doi.org/10.1016/j.vaccine.2019.09.105
  5. 2019
  6. FRESH AIR Collaborators, Brakema, E. A., Tabyshova, A., van der Kleij, R. M. J. J., Sooronbaev, T., Lionis, C., ... van Boven, J. F. M. (2019). The socioeconomic burden of chronic lung disease in low-resource settings across the globe - an observational FRESH AIR study. Respiratory Research, 20(1), [291]. https://doi.org/10.1186/s12931-019-1255-z
  7. Wondimu, A., Cao, Q., Wilschut, J. C., & Postma, M. J. (2019). Factors associated with the uptake of newly introduced childhood vaccinations in Ethiopia: the cases of rotavirus and pneumococcal conjugate vaccines. BMC Public Health, 19(1), [1656]. https://doi.org/10.1186/s12889-019-8002-8
  8. Purba, A., Ascobat, P., Muchtar, A., Wulandari, L., Dik, J-W., d’Arqom, A., & Postma, M. (2019). Cost-Effectiveness Of Culture-Based Versus Empirical Antibiotic Treatment For Hospitalized Adults With Community-Acquired Pneumonia In Indonesia: A Real-World Patient-Database Study. ClinicoEconomics and Outcomes Research, 2019(11), 729-739. https://doi.org/10.2147/CEOR.S224619
  9. Wasir, R., Irawati, S., Makady, A., Postma, M., Goettsch, W., Feenstra, T., & Buskens, E. (2019). The implementation of HTA in medicine pricing and reimbursement policies in Indonesia: Insights from multiple stakeholders. PLoS ONE, 14(11), [e0225626]. https://doi.org/10.1371/journal.pone.0225626
  10. Purba, A., Ascobat, P., Muchtar, A., Wulandari, L., Rosyid, A. N., Purwono, P. B., ... Postma, M. (2019). Multidrug-Resistant Infections Among Hospitalized Adults With Community-Acquired Pneumonia In An Indonesian Tertiary Referral Hospital. Infection and Drug Resistance, 2019(12), 3663-3675. https://doi.org/10.2147/IDR.S217842
  11. van der Schans, J., Hak, E., Postma, M., Breuning, L., Brouwers, J. R. B. J., Ditters, K., ... Wilffert, B. (2019). Effects of Pharmacogenetic Screening for CYP2D6 Among Elderly Starting Therapy With Nortriptyline or Venlafaxine: A Pragmatic Randomized Controlled Trial (CYSCE Trial). Journal of Clinical Psychopharmacology, 39(6), 583-590. https://doi.org/10.1097/JCP.0000000000001129
  12. Emamipour, S., van der Heijden, A. A. W. A., Postma, M., van Boven, J. F. M., & Feenstra, T. (2019). PDB34 A PERSONALIZED SCREENING STRATEGY FOR DIABETIC RETINOPATHY: A COST-EFFECTIVENESS PERSPECTIVE. Value in Health, 22, 578. https://doi.org/10.1016/j.jval.2019.09.916
  13. Arifin, B., van Asselt, A. D. I., Setiawan, D., Atthobari, J., Postma, M. J., & Cao, Q. (2019). Diabetes distress in Indonesian patients with type 2 diabetes: a comparison between primary and tertiary care. BMC Health Services Research, 19(1), [773]. https://doi.org/10.1186/s12913-019-4515-1
  14. Claassens, D. M. F., Vos, G. J. A., Bergmeijer, T. O., Hermanides, R. S., van 't Hof, A. W. J., van der Harst, P., ... ten Berg, J. M. (2019). A Genotype-Guided Strategy for Oral P2Y(12) Inhibitors in Primary PCI. New England Journal of Medicine, 381(17), 1621-1631. https://doi.org/10.1056/NEJMoa1907096
  15. Zeevat, F., van der Schans, J., Boersma, W. G., Boersma, C., & Postma, M. J. (2019). Cost-effectiveness analysis on elderly pneumococcal vaccination in the Netherlands: Challenging the Dutch Health Council's advice. Vaccine, 37(43), 6282-6284. https://doi.org/10.1016/j.vaccine.2019.08.051
  16. van der Pol, S., de Jong, L. A., Vemer, P., Jansen, D. E. M. C., & Postma, M. (2019). Cost-Effectiveness of Sacubitril/Valsartan in Germany: An Application of the Efficiency Frontier. Value in Health, 22(10), 1119-1127. https://doi.org/10.1016/j.jval.2019.06.007
  17. Fens, T., van der Pol, S., Kocks, J. W. H., Postma, M. J., & van Boven, J. F. M. (2019). Economic Impact of Reducing Inappropriate Inhaled Corticosteroids Use in Patients With Chronic Obstructive Pulmonary Disease: ISPOR’s guidance on budget impact in practice . Value in Health, 22(10), 1092-1101. https://doi.org/10.1016/j.jval.2019.05.006
  18. van de Hei, S. J., Poot, C. C., Meijer, E., Metting, E. I., Postma, M. J., Van Boven, J. F. M., ... Kocks, J. W. H. (2019). Effectiveness and acceptability of a smart inhaler asthma self-management programme: a cluster RCT study protocol. European Respiratory Journal, 54. https://doi.org/10.1183/13993003.congress-2019.PA3995
  19. Global Burden of Disease Cancer Collaboration (2019). Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study. JAMA oncology. https://doi.org/10.1001/jamaoncol.2019.2996
  20. Arifin, B., Probandari, A., Purba, A. K. R., Perwitasari, D. A., Schuiling-Veninga, C. C. M., Atthobari, J., ... Postma, M. J. (2019). 'Diabetes is a gift from god' a qualitative study coping with diabetes distress by Indonesian outpatients. Quality of Life Research. https://doi.org/10.1007/s11136-019-02299-2
  21. Gout-Zwart, J. J., de Jong, L. A., Saptenno, L., & Postma, M. J. (2019). Budget Impact Analysis of Metformin Sustained Release for the Treatment of Type 2 Diabetes in The Netherlands. PharmacoEconomics - open. https://doi.org/10.1007/s41669-019-00179-6
  22. van Wijhe, M., de Boer, P. T., de Jong, H. J., van Vliet, H., Wallinga, J., & Postma, M. J. (2019). Trends in governmental expenditure on vaccination programmes in the Netherlands, a historical analysis. Vaccine, 37(38), 5698-5707. https://doi.org/10.1016/j.vaccine.2019.07.097
  23. van Schoonhoven, A. V., Gout-Zwart, J. J., de Vries, M. J. S., van Asselt, A. D. I., Dvortsin, E., Vemer, P., ... Postma, M. J. (2019). Costs of clinical events in type 2 diabetes mellitus patients in the Netherlands: A systematic review. PLoS ONE, 14(9), [e0221856]. https://doi.org/10.1371/journal.pone.0221856
  24. Jacobs, M. S., van Hulst, M., Adeoye, A. M., Tieleman, R. G., Postma, M. J., & Owolabi, M. O. (2019). Atrial Fibrillation in Africa-An Underreported and Unrecognized Risk Factor for Stroke: A Systematic Review. Global heart, 14(3), 269-279. https://doi.org/10.1016/j.gheart.2019.04.003
  25. Soikkeli, F., Hashim, M., Ouwens, M., Postma, M., & Heeg, B. (2019). Extrapolating Survival Data Using Historical Trial-Based a Priori Distributions. Value in Health, 22(9), 1012-1017. https://doi.org/10.1016/j.jval.2019.03.017
  26. Freriks, R. D., Mierau, J. O., van der Schans, J., Groenman, A. P., Hoekstra, P. J., Postma, M. J., ... Cao, Q. (2019). Cost-Effectiveness of Treatments in Children With Attention-Deficit/Hyperactivity Disorder: A Continuous-Time Markov Modeling Approach. MDM policy & practice, 4(2), 2381468319867629. https://doi.org/10.1177/2381468319867629
  27. FRESH AIR Collaborators, van Gemert, F., de Jong, C., Kirenga, B., Musinguzi, P., Buteme, S., ... van Boven, J. F. M. (2019). Effects and acceptability of implementing improved cookstoves and heaters to reduce household air pollution: a FRESH AIR study. npj Primary Care Respiratory Medicine, 29(1), [32]. https://doi.org/10.1038/s41533-019-0144-8
  28. van Aalst, R., Russo, E. M., Neupane, N., Mahmud, S. M., Mor, V., Wilschut, J., ... Young-Xu, Y. (2019). Economic assessment of a high-dose versus a standard-dose influenza vaccine in the US Veteran population: Estimating the impact on hospitalization cost for cardio-respiratory disease. Vaccine, 37(32), 4499-4503. https://doi.org/10.1016/j.vaccine.2019.06.066
  29. Ong, K. J., van Hoek, A. J., Harris, R. J., Figueroa, J., Waters, L., Chau, C., ... Delpech, V. (2019). HIV care cost in England: A cross-sectional analysis of antiretroviral treatment and the impact of generic introduction. Hiv medicine, 20(6), 377-391. https://doi.org/10.1111/hiv.12725
  30. Connolly, M. P., Kotsopoulos, N., Bhatt, A., & Postma, M. J. (2019). Sustainability of public finances: Inclusion of unrelated medical cost only part of the story. European Journal of Health Economics. https://doi.org/10.1007/s10198-019-01075-w
  31. Larmene-Beld, K. H. M., Touwen-Spronk, J., Luttjeboer, J., Taxis, K., & Postma, M. J. (2019). A Cost Minimization Analysis of Ready-to-Administer Prefilled Sterilized Syringes in a Dutch Hospital. Clinical Therapeutics, 41(6), 1139-1150. https://doi.org/10.1016/j.clinthera.2019.04.024
  32. Daskapan, A., Idrus, L. R., Postma, M. J., Wilffert, B., Kosterink, J. G. W., Stienstra, Y., ... Alffenaar, J-W. C. (2019). A Systematic Review on the Effect of HIV Infection on the Pharmacokinetics of First-Line Tuberculosis Drugs. Clinical Pharmacokinetics. https://doi.org/10.1007/s40262-018-0716-8
  33. van der Pol, S., Jacobs, M. S., Meijer, K., Piersma-Wichers, M. G., Tieleman, R. G., Postma, M. J., & van Hulst, M. (2019). Perioperative Bridging of Vitamin K Antagonist Treatment in Patients with Atrial Fibrillation: Only a Very Small Group of Patients Benefits. Europace, 21(5), 716–723. [308]. https://doi.org/10.1093/europace/euy308
  34. GBD 2016 Neurology Collaborators, & Postma, M. (2019). Global, regional, and national burden of neurological disorders, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurology, 18(5), 459-480. https://doi.org/10.1016/S1474-4422(18)30499-X
  35. GBD 2016 Stroke Collaborators, & Postma, M. (2019). Global, regional, and national burden of stroke, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurology, 18(5), 439-458. https://doi.org/10.1016/S1474-4422(19)30034-1
  36. Arifin, B., Idrus, L. R., van Asselt, A. D. I., Purba, F. D., Perwitasari, D. A., Thobari, J. A., ... Postma, M. J. (2019). Health-related quality of life in Indonesian type 2 diabetes mellitus outpatients measured with the Bahasa version of EQ-5D. Quality of Life Research, 28(5), 1179-1190. https://doi.org/10.1007/s11136-019-02105-z
  37. de Jong, L. A., Gout-Zwart, J. J., van den Bosch, M., Koops, M., & Postma, M. J. (2019). Rivaroxaban for non-valvular atrial fibrillation and venous thromboembolism in the Netherlands: a real-world data based cost-effectiveness analysis. Journal of Medical Economics, 22(4), 306-318. https://doi.org/10.1080/13696998.2018.1563404
  38. Fitria, N., van Asselt, A. D. I., & Postma, M. J. (2019). Cost-effectiveness of controlling gestational diabetes mellitus: A systematic review. European Journal of Health Economics, 20(3), 407-417. https://doi.org/10.1007/s10198-018-1006-y
  39. Cao, Q., Buskens, E., Hillege, H. L., Jaarsma, T., Postma, M., & Postmus, D. (2019). Stratified treatment recommendation or one-size-fits-all? A health economic insight based on graphical exploration. European Journal of Health Economics, 20(3), 475-482. https://doi.org/10.1007/s10198-018-1013-z
  40. FRESH AIR Collaborators (2019). COPD's early origins in low-and-middle income countries: what are the implications of a false start? npj Primary Care Respiratory Medicine, 29, [6]. https://doi.org/10.1038/s41533-019-0117-y
  41. Wasserman, M. D., Sings, H. L., Wilson, M. R., Postma, M. J., Breton, M-C., McDade, C., & Farkouh, R. A. (2019). Re-Analysis of Modeling a Switch from a 13-Valent to 10-Valent Pneumococcal Conjugate Vaccine in Canada: Leveraging Real-World Experience from Belgium. Infectious diseases and therapy, 8(1), 1-3. https://doi.org/10.1007/s40121-018-0222-1
  42. Terkola, R., Antonanzas, F., & Postma, M. (2019). Stakeholder opinions on value in healthcare. European Journal of Hospital Pharmacy: Science and Practice, 26(2), 79-84. https://doi.org/10.1136/ejhpharm-2017-001295
  43. Sheikh, S., Biundo, E., Courcier, S., Damm, O., Launay, O., Maes, E., ... Begg, N. (2019). Corrigendum to 'A report on the status of vaccination in Europe' [Vaccine 36 (2018) 4979-4992]. Vaccine, 37(10), 1374-1376. https://doi.org/10.1016/j.vaccine.2019.01.038
  44. Wasir, R., Irawati, S., Makady, A., Postma, M., Goettsch, W., Buskens, E., & Feenstra, T. (2019). Use of medicine pricing and reimbursement policies for universal health coverage in Indonesia. PLoS ONE, 14(2), [e0212328]. https://doi.org/10.1371/journal.pone.0212328
  45. Zakiyah, N., van Asselt, A. D. I., Setiawan, D., Cao, Q., Roijmans, F., & Postma, M. J. (2019). Cost-Effectiveness of Scaling Up Modern Family Planning Interventions in Low- and Middle-Income Countries: An Economic Modeling Analysis in Indonesia and Uganda. Applied Health Economics and Health Policy, 17(1), 66-76. https://doi.org/10.1007/s40258-018-0430-6
  46. Global Burden of Disease Self-Harm Collaborators, Naghavi, M., & Postma, M. (2019). Global, regional, and national burden of suicide mortality 1990 to 2016: Systematic analysis for the Global Burden of Disease Study 2016. BMJ (Clinical research ed.), 364, [l94]. https://doi.org/10.1136/bmj.l94
  47. Gout-Zwart, J. J., Olde Hengel, E. H. J., Hoogland, P., & Postma, M. J. (2019). Budget Impact Analysis of a Renal Point-of-Care Test in Dutch Community Pharmacies to Prevent Antibiotic-Related Hospitalizations. Applied Health Economics and Health Policy, 17(1), 55-63. https://doi.org/10.1007/s40258-018-0426-2
  48. Ong, K. J., Checchi, M., Burns, L., Pavitt, C., Postma, M. J., & Jit, M. (2019). Systematic review and evidence synthesis of non-cervical human papillomavirus-related disease health system costs and quality of life estimates. Sexually Transmitted Infections, 95(1), 28-35. https://doi.org/10.1136/sextrans-2018-053606
  49. Rochanathimoke, O., Riewpaiboon, A., Tharmaphornpilas, P., Jiamsiri, S., Thavorncharoensap, M., & Postma, M. J. (2019). Economic burden of rotavirus diarrhea in Thailand: Report from a pilot study on rotavirus vaccination. Vaccine, 37(4), 587-594. https://doi.org/10.1016/j.vaccine.2018.12.013
  50. Mihajlović, J., Hovius, J. W. R., Sprong, H., Bogovič, P., Postma, M. J., & Strle, F. (2019). Cost-effectiveness of a potential anti-tick vaccine with combined protection against Lyme borreliosis and tick-borne encephalitis in Slovenia. Ticks and tick-borne diseases, 10(1), 63-71. https://doi.org/10.1016/j.ttbdis.2018.08.014
  51. GBD 2017 Influenza Collaborators, & Postma, M. (2019). Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017. The Lancet. Respiratory Medicine, 7(1), 69-89. https://doi.org/10.1016/S2213-2600(18)30496-X
  52. de Jong, L. A., Groeneveld, J., Stevanovic, J., Rila, H., Tieleman, R. G., Huisman, M. V., ... van Hulst, M. (2019). Cost-effectiveness of apixaban compared to other anticoagulants in patients with atrial fibrillation in the real-world and trial settings. PLoS ONE, 14(9), [e0222658]. https://doi.org/10.1371/journal.pone.0222658
Previous 1 2 3 4 5 6 7 8 ...14 Next

ID: 193217

University of Groningen staff: edit these data

print
Follow the UGfacebook twitter linkedin rss instagram youtube